The Impact of Type 2 Diabetes Mellitus on Long-Term Prognosis in Patients of Different Ages with Myocardial Infarction

The objective of the study was to assess the impact of DM2 at baseline on long-term mortality after acute myocardial infarction (MI) among different age groups. The data were taken from: “Register of Acute Myocardial Infarction.” A total of 862 patients were followed for five years after acute myoca...

Full description

Saved in:
Bibliographic Details
Published in:Journal of diabetes research 2018-01, Vol.2018 (2018), p.1-6
Main Authors: Kondratieva, D. S., Andriyanova, A. V., Kuzheleva, E. A., Garganeeva, A. A., Afanasiev, S. A., Popov, S. V.
Format: Article
Language:English
Subjects:
Age
Age Factors
Aged
Angina pectoris
Cardiology
Cardiovascular disease
Comorbidity
Diabetes
Diabetes Mellitus, Type 2 - complications
Female
Follow-Up Studies
Heart attacks
Humans
Hypertension
Male
Medical prognosis
Middle Aged
Mortality
Myocardial Infarction - complications
Myocardial Infarction - diagnosis
Myocardial Infarction - mortality
Patient Admission
Patients
Population
Prognosis
Prospective Studies
Registries
Risk Factors
Russia
Studies
Survival analysis
Treatment Outcome
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The objective of the study was to assess the impact of DM2 at baseline on long-term mortality after acute myocardial infarction (MI) among different age groups. The data were taken from: “Register of Acute Myocardial Infarction.” A total of 862 patients were followed for five years after acute myocardial infarction. The primary endpoint was death from any cause. The patients were categorized into 2 groups based on their ages: group 1—comprised patients older than working age (n=358) and group 2—comprised employable patients (n=504). A total of 208 patients were diagnosed with both cardiovascular disease and DM2. Elderly patients with DM2 had worse prognosis and increased five-year mortality compared with patients of the same age group without DM2. Statistically significant differences in long-term outcomes were found in adult patients (p=0.004) only in group with longer duration of diabetes, unlike the group with DM2 onset. In conclusion, Type 2 DM increased 5-year mortality rate of elderly patients with myocardial infarction. However, younger patients with both myocardial infarction and DM2 had more complications in the early post-MI period compared with patients of the same age group without DM2 but did not show any statistically significant differences in the long-term outcome.
ISSN:2314-6745
2314-6753
DOI:10.1155/2018/1780683